secwatch / observer
8-K filed October 13, 2023, 7:59 PM ET ticker CPMD CIK 0001081938
leadership confidence high sentiment neutral materiality 0.50

CannaPharmaRX appoints Oliver Foeste as CFO; John Cassels departs without disagreement

CANNAPHARMARX, INC.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Oliver Foeste

Chief Financial Officer
CPMD · CANNAPHARMARX, INC.
Effective
2023-10-13
Filed
October 13, 2023, 7:59 PM ET
Effective October 13, 2023, our Board of Directors has determined to appoint Oliver Foeste as Chief Financial Officer.
Departed

John Cassels

Chief Financial Officer
CPMD · CANNAPHARMARX, INC.
Effective
2023-10-13
Successor
Oliver Foeste
Filed
October 13, 2023, 7:59 PM ET
Effective October 13, 2023, John Cassels is being replaced as the Chief Financial Officer (“CFO”) of CannPharmaRX, Inc.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Oliver Foeste was appointed as Chief Financial Officer at CANNAPHARMARX, INC..

Action
appointed
Role
Chief Financial Officer
Exact text from the filing
Effective October 13, 2023, our Board of Directors has determined to appoint Oliver Foeste as Chief Financial Officer.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

John Cassels departed as Chief Financial Officer at CANNAPHARMARX, INC..

Action
replaced
Role
Chief Financial Officer
Exact text from the filing
Effective October 13, 2023, John Cassels is being replaced as the Chief Financial Officer (“CFO”) of CannPharmaRX, Inc.
View on SEC.gov

CANNAPHARMARX, INC. filing history →

Source: SEC EDGAR
accession 0001683168-23-007145
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.